Sofosbuvir Intermedium CAS 21382-82-1 Puritas ≥98.0% (HPLC)

Description:

2-(triphenyl-phosphanylidene) -propionicum acidum ethyl ester

CAS: 21382-82-1

Aspectus: Yellow pulveris

Puritas: ≥98.0% (HPLC)

Intermedia Sofosbuvir (CAS: 1190307-88-0) in curatione Hepatitis C Viris (HCV)

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Commercial Supple Sofosbuvir et media intermedia:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene) phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8

Chemical Properties:

Nomen triphenyl(1-[ethoxycarbonyl]ethylidene) phosphorane
Synonyma 2-(triphenyl-phosphanylidene) -propionicum acidum ethyl ester
CAS Number 21382-82-1
CATTUS Number RF-PI179
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C23H23O2P
M. Pondus 362.41
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Flavus pulveris
Puritas / Analysis Methodus ≥98.0% (HPLC)
Damnum in Siccatio ≤1.0% (60℃, 2h)
Summa PH3P+PH3PO ≤2.0% (HPLC)
Substantia cognata non specificata ≤0.5% (HPLC)
Test Standard Enterprise Standard
Consuetudinem Medium Sofosbuvir (CAS: 1190307-88-0)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

1

FAQ:

Applicatio:

Manufacturer cum High puritate et stabulo Quality
Supple Commercial Sofosbuvir (CAS: 1190307-88-0) et intermedia relativa:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene) phosphorane CAS: 21382-82-1
L-Alanine Isopropyl Ester Hydrochloride CAS: 62062-65-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8

Sofosbuvir medicamentum adhibitum est ad hepatitis curationem C. Commendatur utendum in compositione cum aliis medicamentis (ut velpatasvir) pro genotypes primi lineae curationis HCV 1, 2, 3, 4, 5 et 6; Effectum accipit per inhibitorem nucleotidis analogi agendi, capax est specialiter inhibendi HCV NS5B (dapibus non-structuralibus 5B) RNA-dependens RNA polymerasis.

Epistulam tuam hic scribe et mitte nobis